Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT06873828
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06873828
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06873828. Non-randomized; no masking; primary purpose diagnostic. Start 2025-03 (anticipated); primary completion 2025-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter MonitoringEvaluation of the Efficacy and Safety of Wearable ECG (AT-Patch) in Patients With Hypertrophic Cardiomyopathy Requiring 48-Hour Holter Monitoring
- Acronym
- ATP-HCM
- Condition
- Hypertrophic Cardiomyopathy
- Intervention (Device)
- ATP-C135
- Intervention (Device)
- ATP-C75
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct06873828- Content hash
625dd39bd9a5c470b84962ab004ff5783e06de15300efd075aef1b91dc59a46f